Effects of Luseogliflozin on Left Ventricular Diastolic Function in Patients with Type 2 Diabetes and Established Cardiovascular Disease
Latest Information Update: 26 May 2020
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Left ventricular dysfunction; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Jul 2019 New trial record
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association